Tyrosine kinase inhibitors therapy for hepatocellular carcinoma in patients waiting for liver transplant: is it safe?

被引：0
|
作者：
Conte, G. [1 ]
Mocchegiani, F. [2 ]
Cacciaguerra, A. Benedetti [2 ]
Rossi, R. [3 ]
Vecchi, A. [1 ]
Gaudenzi, F. [2 ]
Roccheggiani, M. [2 ]
Borrelli, G. [2 ]
Quercetti, D. [2 ]
Dalla Bona, E. [1 ]
Nicolini, D. [1 ]
Vivarelli, M. [2 ]
机构：
[1] Osped Riuniti Ancona, Clin Chirurg Epatobiliare Pancreat & Trapianti, Ancona, Italy
[2] Univ Politecn Marche, Ancona, Italy
[3] Ospedali Riuniti Ancona, Clin Chirurg Epatobiliare Pancreat Trapianti, Ancona, Italy
来源：
TRANSPLANTATION | 2023年 / 107卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
eP-460
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [41] Is TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors superior to TACE plus tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: the debate continues
    Yang, Shiye
    Liang, Huoqi
    Li, Xing
    Qian, Jiayi
    Ming, Zhibing
    HEPATOLOGY INTERNATIONAL, 2024, 18 (04) : 1336 - 1337
  • [42] Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors
    Nault, Jean-Charles
    Pigneur, Frederic
    Nelson, Anais Charles
    Costentin, Charlotte
    Tselikas, Lambros
    Katsahian, Sandrine
    Diao, Guoqing
    Laurent, Alexis
    Mallat, Ariane
    Duvoux, Christophe
    Luciani, Alain
    Decaens, Thomas
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (10) : 869 - 876
  • [43] Novel Thienyl-Based Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma
    Ma, Andi
    Biersack, Bernhard
    Goehringer, Nils
    Nitzsche, Bianca
    Hoepfner, Michael
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):
  • [44] Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma
    Xiao-Dong Zhu
    Cheng Huang
    Ying-Hao Shen
    Bin Xu
    Ning-Ling Ge
    Yuan Ji
    Xu-Dong Qu
    Lingli Chen
    Yi Chen
    Mei-Ling Li
    Jin-Jin Zhu
    Zhao-You Tang
    Jian Zhou
    Jia Fan
    Hui-Chuan Sun
    Annals of Surgical Oncology, 2023, 30 : 2782 - 2790
  • [45] Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment
    Chen, Ruyin
    Li, Qiong
    Xu, Shuaishuai
    Ye, Chanqi
    Tian, Tian
    Jiang, Qi
    Shan, Jianzhen
    Ruan, Jian
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [46] Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma
    Zhu, Xiao-Dong
    Huang, Cheng
    Shen, Ying-Hao
    Xu, Bin
    Ge, Ning-Ling
    Ji, Yuan
    Qu, Xu-Dong
    Chen, Lingli
    Chen, Yi
    Li, Mei-Ling
    Zhu, Jin-Jin
    Tang, Zhao-You
    Zhou, Jian
    Fan, Jia
    Sun, Hui-Chuan
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (05) : 2782 - 2790
  • [47] Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment
    Ruyin Chen
    Qiong Li
    Shuaishuai Xu
    Chanqi Ye
    Tian Tian
    Qi Jiang
    Jianzhen Shan
    Jian Ruan
    Cancer Cell International, 22
  • [48] Changing opportunities for liver transplant for patients with hepatocellular carcinoma
    Zendel, Alex
    Watkins, Randall
    Moon, Andrew M.
    Gerber, David A.
    Barritt, A. Sidney
    Desai, Chirag S.
    CLINICAL TRANSPLANTATION, 2022, 36 (05)
  • [49] A New Liver Transplant Priority for Patients with Hepatocellular Carcinoma
    Ravaioli, Matteo
    Grazi, Gian Luca
    Vetrone, Gaetano
    Kimura, Takuya
    Zanello, Matteo
    Ercolani, Giorgio
    Cescon, Matteo
    Varotti, Giovanni
    Del Gaudio, Massimo
    Tuci, Francesco
    Cucchetti, Alessandro
    La Barba, Giuliano
    Vivarelli, Marco
    Lauro, Augusto
    Ramacciato, Giovanni
    Pinna, Antonio Daniele
    HEPATO-GASTROENTEROLOGY, 2008, 55 (86-87) : 1742 - 1745
  • [50] Management of liver transplant patients with recurrence of hepatocellular carcinoma
    Safak, Adem
    Karakaya, Emre
    Yildirim, Sedat
    Okyay, Ozan
    Boyvat, Fatih
    Tseveldorj, Nomingerel
    Boyacioglu, Sedat
    Haberal, Mehmet A.
    TRANSPLANTATION, 2024, 108 (09) : 648 - 648
12345